News Releases – 2000 ArchiveDISCLAIMER FOR ARCHIVES
The information in AstraZeneca Canada’s News Releases Archive was factually accurate on the date of publication. This information remains on our website for historical purposes only. We assume no duty to update the information to reflect subsequent developments. Readers should not rely upon this information as current or accurate after the applicable release dates.
| Dec 12, 2000 |
Arimidex® (anastrozole): The First Aromatase Inhibitor to Show Superiority Over Tamoxifen - Publication of Data in Peer-reviewed Journal |
| Dec 12, 2000 |
Arimidex® (anastrozole): The First Aromatase Inhibitor to Have a Significant Survival Advantage Over Tamoxifen in Advanced Postmenopausal Breast Cancer |
| Nov 7, 2000 |
Cystic Fibrosis Patients May Benefit from Important Trial of Antibiotics |
| Nov 1, 2000 |
Two Out of Three Canadian Women Not Treating Their Migraines |
| Oct 31, 2000 |
New Prostate Cancer Resource Centre Opens to Serve Vancouver Island |
| Oct 30, 2000 |
Heart Clinics Target Breaking a Cycle of Hospital Re-admissions for Congestive Heart Failure |
| Oct 12, 2000 |
First Asthma Inhaler to Show No Long-term Height Impairment in Children |
| Sep 28, 2000 |
Arimidex® (anastrozole) as First-Line Therapy Proves Highly Effective Treatment Sequence for Advanced Breast Cancer |
| Sep 15, 2000 |
Worldwide Incidence of Antibiotic Resistance on the Rise |
| Sep 13, 2000 |
New Studies Offer Hope to Schizophrenia Patients |
| May 19, 2000 |
Initial Clinical Results of Nexium® Presented at Digestive Disease Week |
| Apr 26, 2000 |
Canadian Cancer Society Seminar Explores Cancer Patients' Quality of Life Issues |
| Mar 29, 2000 |
The Canadian Association of Gastroenterology and AstraZeneca Canada Inc. Announce Winners of Consults in Gastroenterology Case Study Competition |
| Mar 9, 2000 |
CADET Hp Study Shows H. pylori Eradication Significantly Benefits Dyspepsia Patients |
|
